181 related articles for article (PubMed ID: 37616377)
1. Transcriptional profiling of immune responses in NHPs after low-dose, VSV-based vaccination against Marburg virus.
Prator CA; Dorratt BM; O'Donnell KL; Lack J; Pinski AN; Ricklefs S; Martens CA; Messaoudi I; Marzi A
Emerg Microbes Infect; 2023 Dec; 12(2):2252513. PubMed ID: 37616377
[TBL] [Abstract][Full Text] [Related]
2. Single Dose of a VSV-Based Vaccine Rapidly Protects Macaques From Marburg Virus Disease.
Marzi A; Jankeel A; Menicucci AR; Callison J; O'Donnell KL; Feldmann F; Pinski AN; Hanley PW; Messaoudi I
Front Immunol; 2021; 12():774026. PubMed ID: 34777392
[TBL] [Abstract][Full Text] [Related]
3. Rapid protection of nonhuman primates against Marburg virus disease using a single low-dose VSV-based vaccine.
O'Donnell KL; Feldmann F; Kaza B; Clancy CS; Hanley PW; Fletcher P; Marzi A
EBioMedicine; 2023 Mar; 89():104463. PubMed ID: 36774693
[TBL] [Abstract][Full Text] [Related]
4. Protection Against Marburg Virus Using a Recombinant VSV-Vaccine Depends on T and B Cell Activation.
Marzi A; Menicucci AR; Engelmann F; Callison J; Horne EJ; Feldmann F; Jankeel A; Feldmann H; Messaoudi I
Front Immunol; 2018; 9():3071. PubMed ID: 30723475
[TBL] [Abstract][Full Text] [Related]
5. Durability of a vesicular stomatitis virus-based marburg virus vaccine in nonhuman primates.
Mire CE; Geisbert JB; Agans KN; Satterfield BA; Versteeg KM; Fritz EA; Feldmann H; Hensley LE; Geisbert TW
PLoS One; 2014; 9(4):e94355. PubMed ID: 24759889
[TBL] [Abstract][Full Text] [Related]
6. Single-Dose Trivalent VesiculoVax Vaccine Protects Macaques from Lethal Ebolavirus and Marburgvirus Challenge.
Matassov D; Mire CE; Latham T; Geisbert JB; Xu R; Ota-Setlik A; Agans KN; Kobs DJ; Wendling MQS; Burnaugh A; Rudge TL; Sabourin CL; Egan MA; Clarke DK; Geisbert TW; Eldridge JH
J Virol; 2018 Feb; 92(3):. PubMed ID: 29142131
[TBL] [Abstract][Full Text] [Related]
7. Preexisting Immunity Does Not Prevent Efficacy of Vesicular Stomatitis Virus-Based Filovirus Vaccines in Nonhuman Primates.
Marzi A; Feldmann F; O'Donnell KL; Hanley PW; Messaoudi I; Feldmann H
J Infect Dis; 2023 Nov; 228(Suppl 7):S671-S676. PubMed ID: 37290042
[TBL] [Abstract][Full Text] [Related]
8. Single-injection vaccine protects nonhuman primates against infection with marburg virus and three species of ebola virus.
Geisbert TW; Geisbert JB; Leung A; Daddario-DiCaprio KM; Hensley LE; Grolla A; Feldmann H
J Virol; 2009 Jul; 83(14):7296-304. PubMed ID: 19386702
[TBL] [Abstract][Full Text] [Related]
9. Species-specific immunogenicity and protective efficacy of a vesicular stomatitis virus-based Sudan virus vaccine: a challenge study in macaques.
Marzi A; Fletcher P; Feldmann F; Saturday G; Hanley PW; Feldmann H
Lancet Microbe; 2023 Mar; 4(3):e171-e178. PubMed ID: 36739878
[TBL] [Abstract][Full Text] [Related]
10. A highly attenuated Vesiculovax vaccine rapidly protects nonhuman primates against lethal Marburg virus challenge.
Woolsey C; Cross RW; Agans KN; Borisevich V; Deer DJ; Geisbert JB; Gerardi C; Latham TE; Fenton KA; Egan MA; Eldridge JH; Geisbert TW; Matassov D
PLoS Negl Trop Dis; 2022 May; 16(5):e0010433. PubMed ID: 35622847
[TBL] [Abstract][Full Text] [Related]
11. A Cloned Recombinant Vesicular Stomatitis Virus-Vectored Marburg Vaccine, PHV01, Protects Guinea Pigs from Lethal Marburg Virus Disease.
Zhu W; Liu G; Cao W; He S; Leung A; Ströher U; Fairchild MJ; Nichols R; Crowell J; Fusco J; Banadyga L
Vaccines (Basel); 2022 Jun; 10(7):. PubMed ID: 35891170
[TBL] [Abstract][Full Text] [Related]
12. Rapid Protection from COVID-19 in Nonhuman Primates Vaccinated Intramuscularly but Not Intranasally with a Single Dose of a Vesicular Stomatitis Virus-Based Vaccine.
Furuyama W; Shifflett K; Pinski AN; Griffin AJ; Feldmann F; Okumura A; Gourdine T; Jankeel A; Lovaglio J; Hanley PW; Thomas T; Clancy CS; Messaoudi I; O'Donnell KL; Marzi A
mBio; 2022 Feb; 13(1):e0337921. PubMed ID: 35012339
[TBL] [Abstract][Full Text] [Related]
13. Monovalent virus-like particle vaccine protects guinea pigs and nonhuman primates against infection with multiple Marburg viruses.
Swenson DL; Warfield KL; Larsen T; Alves DA; Coberley SS; Bavari S
Expert Rev Vaccines; 2008 May; 7(4):417-29. PubMed ID: 18444889
[TBL] [Abstract][Full Text] [Related]
14. Cross-protection against Marburg virus strains by using a live, attenuated recombinant vaccine.
Daddario-DiCaprio KM; Geisbert TW; Geisbert JB; Ströher U; Hensley LE; Grolla A; Fritz EA; Feldmann F; Feldmann H; Jones SM
J Virol; 2006 Oct; 80(19):9659-66. PubMed ID: 16973570
[TBL] [Abstract][Full Text] [Related]
15. Postexposure protection against Marburg haemorrhagic fever with recombinant vesicular stomatitis virus vectors in non-human primates: an efficacy assessment.
Daddario-DiCaprio KM; Geisbert TW; Ströher U; Geisbert JB; Grolla A; Fritz EA; Fernando L; Kagan E; Jahrling PB; Hensley LE; Jones SM; Feldmann H
Lancet; 2006 Apr; 367(9520):1399-404. PubMed ID: 16650649
[TBL] [Abstract][Full Text] [Related]
16. Virus-Like Particle Vaccination Protects Nonhuman Primates from Lethal Aerosol Exposure with Marburgvirus (VLP Vaccination Protects Macaques against Aerosol Challenges).
Dye JM; Warfield KL; Wells JB; Unfer RC; Shulenin S; Vu H; Nichols DK; Aman MJ; Bavari S
Viruses; 2016 Apr; 8(4):94. PubMed ID: 27070636
[TBL] [Abstract][Full Text] [Related]
17. Vesicular stomatitis virus-based vaccines protect nonhuman primates against aerosol challenge with Ebola and Marburg viruses.
Geisbert TW; Daddario-Dicaprio KM; Geisbert JB; Reed DS; Feldmann F; Grolla A; Ströher U; Fritz EA; Hensley LE; Jones SM; Feldmann H
Vaccine; 2008 Dec; 26(52):6894-900. PubMed ID: 18930776
[TBL] [Abstract][Full Text] [Related]
18. A Recombinant Rabies Virus Expressing the Marburg Virus Glycoprotein Is Dependent upon Antibody-Mediated Cellular Cytotoxicity for Protection against Marburg Virus Disease in a Murine Model.
Keshwara R; Hagen KR; Abreu-Mota T; Papaneri AB; Liu D; Wirblich C; Johnson RF; Schnell MJ
J Virol; 2019 Mar; 93(6):. PubMed ID: 30567978
[TBL] [Abstract][Full Text] [Related]
19. Antiviral Innate Responses Induced by VSV-EBOV Vaccination Contribute to Rapid Protection.
Menicucci AR; Jankeel A; Feldmann H; Marzi A; Messaoudi I
mBio; 2019 May; 10(3):. PubMed ID: 31138743
[TBL] [Abstract][Full Text] [Related]
20. Vector choice determines immunogenicity and potency of genetic vaccines against Angola Marburg virus in nonhuman primates.
Geisbert TW; Bailey M; Geisbert JB; Asiedu C; Roederer M; Grazia-Pau M; Custers J; Jahrling P; Goudsmit J; Koup R; Sullivan NJ
J Virol; 2010 Oct; 84(19):10386-94. PubMed ID: 20660192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
